169 related articles for article (PubMed ID: 20571519)
1. Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride.
Slifstein M; Suckow RF; Javitch JA; Cooper T; Lieberman J; Abi-Dargham A
J Cereb Blood Flow Metab; 2011 Jan; 31(1):293-304. PubMed ID: 20571519
[TBL] [Abstract][Full Text] [Related]
2. Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder.
Rosell DR; Zaluda LC; McClure MM; Perez-Rodriguez MM; Strike KS; Barch DM; Harvey PD; Girgis RR; Hazlett EA; Mailman RB; Abi-Dargham A; Lieberman JA; Siever LJ
Neuropsychopharmacology; 2015 Jan; 40(2):446-53. PubMed ID: 25074637
[TBL] [Abstract][Full Text] [Related]
3. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia.
Girgis RR; Van Snellenberg JX; Glass A; Kegeles LS; Thompson JL; Wall M; Cho RY; Carter CS; Slifstein M; Abi-Dargham A; Lieberman JA
J Psychopharmacol; 2016 May; 30(5):428-35. PubMed ID: 26966119
[TBL] [Abstract][Full Text] [Related]
4. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
5. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
[TBL] [Abstract][Full Text] [Related]
6. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
[TBL] [Abstract][Full Text] [Related]
7. Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
Catafau AM; Searle GE; Bullich S; Gunn RN; Rabiner EA; Herance R; Radua J; Farre M; Laruelle M
J Cereb Blood Flow Metab; 2010 May; 30(5):985-93. PubMed ID: 20029452
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
[TBL] [Abstract][Full Text] [Related]
9. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
10. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.
Kodaka F; Ito H; Takano H; Takahashi H; Arakawa R; Miyoshi M; Okumura M; Otsuka T; Nakayama K; Halldin C; Farde L; Suhara T
Int J Neuropsychopharmacol; 2011 Feb; 14(1):83-9. PubMed ID: 20860881
[TBL] [Abstract][Full Text] [Related]
11. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
Seneca N; Finnema SJ; Farde L; Gulyás B; Wikström HV; Halldin C; Innis RB
Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
[TBL] [Abstract][Full Text] [Related]
12. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
Rosa-Neto P; Doudet DJ; Cumming P
Neuroimage; 2004 Jul; 22(3):1076-83. PubMed ID: 15219579
[TBL] [Abstract][Full Text] [Related]
13. Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia.
Arakawa R; Ito H; Takano A; Takahashi H; Morimoto T; Sassa T; Ohta K; Kato M; Okubo Y; Suhara T
Psychopharmacology (Berl); 2008 Apr; 197(2):229-35. PubMed ID: 18058087
[TBL] [Abstract][Full Text] [Related]
14. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.
Farde L
Psychopharmacology (Berl); 1992; 107(1):23-9. PubMed ID: 1534178
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor-mediated regulation of striatal cholinergic activity: positron emission tomography studies with norchloro[18F]fluoroepibatidine.
Ding YS; Logan J; Bermel R; Garza V; Rice O; Fowler JS; Volkow ND
J Neurochem; 2000 Apr; 74(4):1514-21. PubMed ID: 10737608
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA.
Finnema SJ; Halldin C; Bang-Andersen B; Gulyás B; Bundgaard C; Wikström HV; Farde L
Synapse; 2009 May; 63(5):378-89. PubMed ID: 19173265
[TBL] [Abstract][Full Text] [Related]
17. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
Boy C; Klimke A; Holschbach M; Herzog H; Mühlensiepen H; Rota Kops E; Sonnenberg F; Gaebel W; Stöcklin G; Markstein R; Müller-Gärtner HW
Synapse; 1998 Dec; 30(4):341-50. PubMed ID: 9826226
[TBL] [Abstract][Full Text] [Related]
18. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
[TBL] [Abstract][Full Text] [Related]
19. Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats.
Wilkerson A; Levin ED
Neuroscience; 1999 Mar; 89(3):743-9. PubMed ID: 10199609
[TBL] [Abstract][Full Text] [Related]
20. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.
Shotbolt P; Tziortzi AC; Searle GE; Colasanti A; van der Aart J; Abanades S; Plisson C; Miller SR; Huiban M; Beaver JD; Gunn RN; Laruelle M; Rabiner EA
J Cereb Blood Flow Metab; 2012 Jan; 32(1):127-36. PubMed ID: 21878947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
